Abstract Details

Title Efficacy and Safety of Crisugabalin in Patients With Moderate-to-Severe Central Neuropathic Pain: A Phase 3 Randomized Clinical Trial

Topic Pain

Presentation(s) LS2 - Late-breaking Science 2 (6:15 PM-6:21 PM)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Xiaochong Fan, MD PRESENTER	Dr. Fan has nothing to disclose.
Youxiang CUI	Dr. CUI has nothing to disclose.
yufeng Tang, MD	Dr. Tang has nothing to disclose.
Bo Liu	Dr. Liu has nothing to disclose.
Songbo Li	Dr. Li has nothing to disclose.
Yang-Kun Chen, MD, PhD	Dr. Chen has nothing to disclose.
Qinglai Wang	Prof. Wang has nothing to disclose.
Yaming Li	Mr. Li has received personal compensation for serving as an employee of Haisco Pharmaceutical Group Co., Ltd..
Shiyu Yan	Dr. Yan has received personal compensation for serving as an employee of Haisco Pharmaceutical Group Co., Ltd..
Qiuyue Pan, PhD	Dr. Pan has received personal compensation for serving as an employee of Haisco Pharmaceutical Group Co., Ltd..
Dongsheng Fan	Dr. Fan has nothing to disclose.